# Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease

> **NCT03298399** · PHASE1 · WITHDRAWN · sponsor: **Emory University**

## Conditions studied

- Sickle Cell Disease

## Interventions

- **BIOLOGICAL:** Autologous MSCs
- **BIOLOGICAL:** Autologous MSCs
- **BIOLOGICAL:** Autologous MSCs

## Key facts

- **NCT ID:** NCT03298399
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-12-21
- **Primary completion:** 2018-10-25
- **Final completion:** 2018-10-25
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study stopped due to a competing trial.
- **Last updated:** 2018-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03298399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03298399, "Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03298399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*